NEW! See our reimagined interface 🙌🏼 Explore now →
See what you could achieve with DoseMeRx.
Precision dosing using Bayesian dose individualization has been shown to have such significant benefits that some leading researchers believe that further clinical trials may be unethical, due to the control arm being required to receive substandard treatment.
The following papers are just some of the randomized clinical trials that show the patient benefits of precision dosing and dose-individualization:
Precision dosing reduces adverse events. The following RCTs demonstrate some of these benefits:
Improving patient outcomes and reducing adverse events is highly cost-effective. The studies below quantify the cost-benefits of precision dosing:
DoseMeRx is the only HITRUST CSF certified Bayesian dosing platform.
By implementing HITRUST CSF requirements we have addressed every standard and implementation in the HIPAA Security Rule.